Loading...

PE/Cyanine7 anti-mouse CD8a Antibody

Pricing & Availability
Clone
53-6.7 (See other available formats)
Regulatory Status
RUO
Other Names
T8, Lyt2, Ly-2
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
53-67_PECyanine7_CD8a_Antibody_1_071124
C57BL/6 mouse splenocytes were stained with anti-mouse CD3ε (clone 145-2C11) FITC and anti-mouse CD8a (clone 53-6.7) PE/Cyanine7 (left) or rat IgG2a, κ PE/Cyanine7 isotype control (right).
  • 53-67_PECyanine7_CD8a_Antibody_1_071124
    C57BL/6 mouse splenocytes were stained with anti-mouse CD3ε (clone 145-2C11) FITC and anti-mouse CD8a (clone 53-6.7) PE/Cyanine7 (left) or rat IgG2a, κ PE/Cyanine7 isotype control (right).
See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
100721 25 µg $68
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100722 100 µg $198
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.

Product Details
Technical data sheet

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Additional Product Notes

BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.

Application References

(PubMed link indicates BioLegend citation)
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  29. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  30. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Ding Z, et al. 2017. Sci Rep. 10.1038/s41598-017-12488-z. PubMed
  2. Tello‐Lafoz M, et al. 2017. Sci Rep. . 10.1038/s41598-017-16370-w. PubMed
  3. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  4. Jarick KJ, et al. 2018. Front Immunol. 9:1468. PubMed
  5. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  6. Dar HY, et al. 2018. Sci Rep. 8:2503. PubMed
  7. Dar HY, et al. 2018. Bone Rep. 8:46. PubMed
  8. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  9. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  10. Nakamura‐Ishizu A et al. 2018. Cell reports. 25(7):1772-1785 . PubMed
  11. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  12. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  13. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  14. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  15. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  16. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  17. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  18. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  19. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  20. Tan DQ, et al. 2019. Cell Rep. 26:2316. PubMed
  21. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  22. Emily A Thompson et al. 2019. Cell reports. 26(11):2859-2867 . PubMed
  23. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  24. Seo JB, et al. 2019. Nat Metab. 1:86. PubMed
  25. Lee YS, et al. 2019. Sci Adv. 5:eaaw4176. PubMed
  26. Chow MT et al. 2019. Immunity. 50(6):1498-1512 . PubMed
  27. Nelson CE et al. 2019. Cell Rep. 28(12):3092-3104 . PubMed
  28. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  29. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  30. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  31. Wu FTH, et al. 2019. Br J Cancer. 120:196. PubMed
  32. Silva DA, et al. 2019. Nature. 565:186. PubMed
  33. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  34. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  35. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  36. He J, et al. 2020. Evid Based Complement Alternat Med. 2020:5637507. PubMed
  37. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  38. Kyburz A, et al. 2019. J Allergy Clin Immunol. 143:1496. PubMed
  39. Cheng Y, et al. 2019. Clin Cancer Res. 25:2621. PubMed
  40. Brenner E, et al. 2020. Nat Commun. 11:1335. PubMed
  41. Pietronigro E, et al. 2019. Sci Rep. 9:12055. PubMed
  42. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  43. Hung PJ, et al. 2018. Mol Cell. 71:332. PubMed
  44. Li J, et al. 2018. Immunity. 49:178. PubMed
  45. Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed
  46. Domingo–Gonzalez R, et al. 2020. eLife. 9:e56890.. PubMed
  47. Reinke S, et al. 2020. Cell Reports. 30(8):2501-2511. PubMed
  48. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  49. Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed
  50. Muri J, et al. 2020. eLife. 9:e53627.. PubMed
  51. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  52. Kim SH, et al. 2020. Neoplasia. 1.3375. PubMed
  53. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  54. Liu J, et al. 2012. PLoS One. 7:e44044. PubMed
  55. Neubert K, et al. 2014. J Immunol. 192:5830. PubMed
  56. Sakthivel P, et al. 2014. PLoS One. 9:100970. PubMed
  57. Wei M, et al. 2014. Protein Eng Des Sel. 27:289. PubMed
  58. Abramowski P, et al. 2014. J Neuroimmunol. 274:111. PubMed
  59. Mykkänen O, et al. 2014. PLoS One. 9:114790. PubMed
  60. Sullivan B, et al. 2015. PLoS Pathog. 11:1004588. PubMed
  61. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  62. Itoga M, et al. 2015. PLoS One. 10: e0123210. PubMed
  63. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  64. Yabas M, et al. 2016. PLoS One. 11: 0146774. PubMed
  65. Guo Z, et al. 2016. Nat Commun. 7:10307. PubMed
  66. Ariyoshi Y, et al. 2016. Gene Ther. 10.1038/gt.2016.7. PubMed
  67. Baglaenko Y, et al. 2016. PLoS One. 11: 0150515. PubMed
  68. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  69. X X, et al. 2016. J Immunol . 197: 1683-1691. PubMed
  70. Marco Barros R, et al. 2016. Cell. 167: 203-218. PubMed
  71. Collinson-Pautz M, et al. 2016. PLoS One. 11:e0164547. PubMed
  72. Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed
  73. Timilshina M, et al. 2017. PLoS One. 10.1371/journal.pone.0168942. PubMed
  74. Ma F, et al. 2020. Cell Death Dis. 1.172222222. PubMed
  75. Ye Y, et al. 2020. Genome Med. 0.557638889. PubMed
  76. Amor C, et al. 2020. Nature. 583:127. PubMed
  77. Köchl R, et al. 2020. Elife. 9:00. PubMed
  78. Walter F, et al. 2020. PLoS One. 15:e0239369. PubMed
  79. Jandke A, et al. 2020. Nat Commun. 3.075694444. PubMed
  80. Dumas AA, et al. 2020. EMBO J. 39:e103790. PubMed
  81. Gomzikova MO, et al. 2020. Pharmaceutics. 12:00. PubMed
  82. Ligon MM, et al. 2020. Mucosal Immunol. 1.172222222. PubMed
  83. Abdelsamed HA, et al. 2020. Nat Immunol. 1.276388889. PubMed
  84. Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed
  85. Li J, et al. 2020. Cancer Immunol Res. 0.529166667. PubMed
  86. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  87. Wang Y, et al. 2021. Sci Rep. 1.429861111. PubMed
  88. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  89. Sheng J, et al. 2021. eLife. 10:00. PubMed
  90. Szafran BN, et al. 2021. Chemical Research in Toxicology. 34(6):1556-1571. PubMed
  91. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  92. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  93. Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed
  94. Gong Y, et al. 2020. Cell Metabolism. 33(1):51-64.e9. PubMed
  95. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  96. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  97. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  98. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  99. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  100. Avgustinova A, et al. 2021. Cell Stem Cell. . PubMed
  101. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  102. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  103. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  104. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  105. Zhao B, et al. 2021. Cell Reports. 36(3):109401. PubMed
  106. Goc J, et al. 2021. Cell. 184:5015. PubMed
  107. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  108. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  109. Mulas F, et al. 2020. Cell Mol Immunol. . PubMed
  110. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  111. Li J, et al. 2020. Cancer Discov. . PubMed
  112. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  113. Wei SC, et al. 2020. Cancer Discov. . PubMed
  114. Calabrese DR, et al. 2020. J Clin Invest. . PubMed
  115. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  116. Niderla-Bielinska J, et al. 2021. Int J Mol Sci. :22. PubMed
  117. Sharma R, et al. 2021. J Neuroinflammation. 72:18. PubMed
  118. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  119. Lechuga-Vieco AV, et al. 2020. Sci Adv. 6:eaba5345. PubMed
  120. Alsaleh G, et al. 2020. Elife. 9: . PubMed
  121. Tan X, et al. 2021. Sci Adv. 7: . PubMed
  122. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  123. Saito S, et al. 2020. Nutrients. 12:. PubMed
  124. Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed
  125. Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed
  126. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  127. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  128. Lu Y, et al. 2021. Gastroenterology. 161:575. PubMed
  129. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  130. Baram T, et al. 2021. Cells. 10:. PubMed
  131. Vella JL, et al. 2021. Life Sci Alliance. 4:. PubMed
  132. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  133. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  134. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  135. Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed
  136. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  137. Rouse MD, et al. 2020. Front Microbiol. 11:414. PubMed
  138. Reese B, et al. 2020. J Immunol. 205:3218. PubMed
  139. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  140. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  141. Sapra L, et al. 2021. Sci Rep. 11:1807. PubMed
  142. Mehta AK, et al. 2021. Nat Cancer. 2:66. PubMed
  143. Guo HF, et al. 2021. Commun Biol. 4:482. PubMed
  144. Bhatt D, et al. 2021. J Exp Med. 218:. PubMed
  145. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  146. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  147. Xiao Y, et al. 2021. Cell. 184:6037. PubMed
  148. Cai B, et al. 2021. Mol Cancer. 20:165. PubMed
  149. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
  150. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  151. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  152. Wang X, et al. 2022. Elife. 11:. PubMed
  153. Lopes N, et al. 2022. Elife. 11:. PubMed
  154. Yang Y, et al. 2022. Elife. 11:. PubMed
  155. Tang S, et al. 2022. Virol J. 19:32. PubMed
  156. Schmit T, et al. 2022. Cell Rep. 38:110456. PubMed
  157. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  158. Zebley CC, et al. 2021. Cell Rep. 37:109796. PubMed
  159. Wang D, et al. 2022. EMBO Rep. 23:e53691. PubMed
  160. Lang V, et al. 2021. Elife. 10:. PubMed
  161. Taniguchi H, et al. 2022. Cell Rep. 39:110814. PubMed
  162. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  163. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  164. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  165. Schönberger K, et al. 2022. STAR Protoc. 3:101408. PubMed
  166. Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed
  167. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  168. Chen WS, et al. 2021. Cell Rep. 37:109974. PubMed
  169. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  170. Ferrere G, et al. 2021. JCI Insight. 6:. PubMed
  171. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  172. Hu J, et al. 2021. Sci Adv. 7:. PubMed
  173. Goubet AG, et al. 2021. Cell Death Differ. 28:2276. PubMed
  174. Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed
  175. Lal JC, et al. 2021. Breast Cancer Res. 23:83. PubMed
  176. del Rio ML, et al. 2021. Transl Res. Online ahead of print.. PubMed
  177. Snyder LM, et al. 2021. PLoS Pathog. 17:e1009970. PubMed
  178. Fearon AE, et al. 2021. iScience. 24:103143. PubMed
  179. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  180. Kim S, et al. 2021. Elife. 10:. PubMed
  181. Bell CR, et al. 2022. Nat Commun. 13:2063. PubMed
  182. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  183. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  184. Mei S, et al. 2022. Front Immunol. 13:911164. PubMed
  185. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  186. Zhang S, et al. 2022. Nat Commun. 13:4744. PubMed
  187. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  188. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  189. Pantelidou C, et al. 2022. NPJ Breast Cancer. 8:102. PubMed
  190. Fitzpatrick Z, et al. 2020. Nature. 587:472. PubMed
  191. Kojima H, et al. 2021. Scand J Immunol. 93:e13020. PubMed
  192. Alotaibi F, et al. 2021. Front Immunol. 11:584937. PubMed
  193. Petty AJ, et al. 2021. JCI Insight. 6:. PubMed
  194. Anger-Góra N, et al. 2021. Oncol Lett. 22:582. PubMed
  195. Liu Q, et al. 2021. Adv Mater. 33:e2102852. PubMed
  196. Andreas N, et al. 2021. Arthritis Res Ther. 23:222. PubMed
  197. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  198. Plaza-Sirvent C, et al. 2021. Front Immunol. 12:705436. PubMed
  199. Sakamoto K, et al. 2021. Immunity. 54:2321. PubMed
  200. Pinho S, et al. 2022. Nat Cell Biol. 24:290. PubMed
  201. Hsu M, et al. 2022. Nat Immunol. 23:581. PubMed
  202. Daniel CJ, et al. 2022. Mol Cancer Res. 20:1151. PubMed
  203. Leier A, et al. 2022. Mol Ther Nucleic Acids. 28:261. PubMed
  204. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  205. Zhao F, et al. 2022. Front Immunol. 13:873720. PubMed
  206. Denk D, et al. 2022. Immunity. 55:2059. PubMed
  207. Vick SC, et al. 2021. J Immunol. 207:2598. PubMed
  208. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  209. Xin B, et al. 2022. Hepatology. 76:630. PubMed
  210. Schnell A, et al. 2021. Cell. 184:6281. PubMed
  211. Fu A, et al. 2022. Cell. 185:1356. PubMed
  212. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  213. Guttman O, et al. 2022. J Cell Biol. 221: . PubMed
  214. Zhu J, et al. 2022. Research (Wash D C). 2022:9816272. PubMed
  215. Poh AR, et al. 2022. Cell Rep. 41:111479. PubMed
  216. Gao Y, et al. 2022. Cell Res. 32:1086. PubMed
  217. Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed
  218. Yang H, et al. 2023. Cell Death Differ. 30:560. PubMed
  219. Horkova V, et al. 2023. Nat Immunol. 24:174. PubMed
  220. Roh YJ, et al. 2023. Lab Anim Res. 39:2. PubMed
  221. Giannou AD, et al. 2023. Immunity. 56:125. PubMed
  222. Briukhovetska D, et al. 2023. Immunity. 56:143. PubMed
  223. Wang C, et al. 2023. Exp Mol Med. 55:347. PubMed
  224. Wang J, et al. 2023. Inflamm Regen. 43:12. PubMed
  225. Georgiev GI, et al. 2022. Cell Chem Biol. 29:811. PubMed
  226. Zhu Z, et al. 2022. Clin Cancer Res. 28:4820. PubMed
  227. Sugitani N, et al. 2022. Cell Rep. 40:111371. PubMed
  228. Bajaj R, et al. 2022. Cell Rep. 40:111429. PubMed
  229. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  230. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  231. Schönberger K, et al. 2023. Anal Chem. 95:4325. PubMed
  232. Li L, et al. 2023. iScience. 26:106095. PubMed
  233. Liu N, et al. 2023. Cell Death Dis. 14:170. PubMed
  234. Cheng K, et al. 2023. Small. 19:e2300125. PubMed
  235. Li G, et al. 2023. Cell Death Dis. 14:185. PubMed
  236. Guo D, et al. 2023. Cell Biosci. 13:51. PubMed
  237. Wang Y, et al. 2023. Front Bioeng Biotechnol. 11:1128268. PubMed
  238. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  239. Sun R, et al. 2023. PLoS One. 18:e0282722. PubMed
  240. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
RRID
AB_312760 (BioLegend Cat. No. 100721)
AB_312761 (BioLegend Cat. No. 100722)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8alpha on UniProt.org
Go To Top Version: 2    Revision Date: 01/21/2014

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account